Quantcast
Last updated on April 18, 2014 at 16:34 EDT

Latest Guanidines Stories

2013-05-20 23:24:52

Nurigene gives free skincare kits to all entrants in their month-long “wrinkle” story contest San Francisco, CA (PRWEB) May 20, 2013 Nurigene, the leader in scientific skin care, is celebrating and honoring Mothers throughout the month of May with a social media contest that awards free skin care kits to all participants and their mothers. Entrants have been sharing their humorous stories and fun photos about how they gave their mom her wrinkles at the Facebook Page...

2013-05-20 08:26:55

SAN DIEGO, May 20, 2013 /PRNewswire/ -- Enrollment of patients with Type 2 diabetes is underway in Elcelyx Therapeutics' Phase 2b dose-finding clinical trial of product candidate NewMet(TM), a delayed-release formulation of generic metformin, the foundational treatment for Type 2 diabetes. Elcelyx expects to complete enrollment of 240 patients in the multicenter U.S. program in June. Results of the trial's primary endpoint of change in fasting plasma glucose are expected in late summer, and...

2013-05-17 23:20:43

Revolutionary supplement can lower your blood pressure and improve your quality of life Wainwright, Alberta, Canada (PRWEB) May 17, 2013 ProArgi9Challenge.net, a website dedicated to giving health conscious consumers the opportunity to buy and experience ProArgi-9+, has announced its offering of the acclaimed supplement to the public. ProArgi-9+ is now for sale via ProArgi9Challenge.net and can be purchased through a number of secure, easy payment methods. People can lower their blood...

2013-05-14 08:32:34

TAIPEI, Taiwan, May 14, 2013 /PRNewswire/ -- TWi Pharmaceuticals, Inc. (Taiwan OTC: 4180) today announced that it has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration (U.S. FDA). Guanfacine Hydrochloride Extended-Release Tablet is a central alpha2A-adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity...

2013-05-09 08:27:20

SACRAMENTO, Calif., May 9, 2013 /PRNewswire-iReach/ -- Creatine Marketing, one of Sacramento's top digital marketing agencies, is thrilled to announce a merger with MXSweb, a 14-year-old brand enhancement and website development company. With this union, Creatine Marketing will combine its proficiency in social media creation, education and management with the unmatchable talent of the MXSweb team's website and logo design. (Photo: http://photos.prnewswire.com/prnh/20130509/CG10244) Since...

2013-04-29 16:01:28

Drug manufacturer did not submit suitable data in its dossier The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this fixed combination product offers an added...

2013-04-18 08:32:35

Global Phase 3 Clinical Trial to Study NT-300 for Treatment of Acute Uncomplicated Influenza TAMPA, Fla., April 18, 2013 /PRNewswire/ -- Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza. (Logo: http://photos.prnewswire.com/prnh/20100201/FL47022LOGO ) The Phase 3 clinical trial has been initiated in the United States, will continue in Australia and New...

2013-04-17 12:25:20

Polaris Scientific Colleagues from Several University Cancer Centers Present Data at 2013 AACR Meeting in Washington, DC SAN DIEGO, April 17, 2013 /PRNewswire/ -- Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if...

2013-04-15 23:00:27

In response to an article published by the Natural Standard detailing a new study showing a decline in muscle mass for patients with type 2 diabetes, Muscular Development magazine suggests the use of creatine to help maintain muscle mass. Setauket, NY (PRWEB) April 15, 2013 On April 15, Muscular Development Magazine responds to an article published by the Natural Standard outlining a new study that shows decreases in muscle mass and strength in type 2 diabetes patients. According to the...

2013-03-13 16:25:54

PITTSBURGH, March 13, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into a settlement agreement with Shionogi Inc. and Andrx that will resolve patent litigation related to Metformin Hydrochloride Extended-release Tablets USP, 500 mg and 1000 mg. This product is the generic version of Shionogi's Fortamet(®), and is indicated as an adjunct to diet and exercise to lower blood glucose.(1) Under the terms of the...